|
Ariel is a research director at the French National Institute of Health and Medical Research (INSERM), co-founder and vice-director of the Centre for Research and Interdisciplinarity (CRI; www.cri-paris.org) and co-director of its AIV M.Sc. program. He graduated from the ‘Amirim’ interdisciplinary program with a major in Chemistry (Hebrew University, Jerusalem) and received my M.Sc. and Ph.D. from the Weizmann Institute of Science for work on enzyme models, antibody conformational changes and directed evolution. After a research period on protein structures at the Scripps Institute (California, USA), and postdoctoral work in Paris on bacterial genetics, he integrated in the Evolutionary Systems Biology team (now: SEED: Systems Engineering and Evolution Dynamics) at INSERM.
His research interests revolve around applying Physical, Chemical and Systems/Synthetic Biological approaches to study variability between clonal individuals. Major contributions in past 5 years include publications in Nature, Science, Cell and PNAS journals for which he is an occasional reviewer. He coordinates the Citizen CyberLab European project (citizencyberlab.eu), a national research agency interdisciplinary consortium and takes part in the Axa foundation Chair on Longevity. He is also involved in research at the interface between art & science. |
OSPF is a supporter of the Open Source Pharma Movement and Community
|
|